| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |